Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...

This recall involves removing certain devices from where they are used or sold and does not apply to the FreeStyle Libre 3 reader or app. The FreeStyle Libre 3 Continuous Glucose Monitoring System ...

Abbott’s FreeStyle Libre devices involve a small sensor applied ... transmitting the data to a reader or smartphone app. By adding automated insulin delivery technology, the system will be ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

The film will have a limited theatrical run in Los Angeles and Chicago prior to being released on VOD and DVD.

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

EXCLUSIVE: Freestyle Digital Media, the digital film distribution division of Byron Allen’s Allen Media Group, has acquired North American rights to Daruma, an indie drama exec produced by Oscar ...

Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...